QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput versionBusiness Wire • 01/10/22
QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New CollaborationsBusiness Wire • 01/07/22
Denovo Biopharma and QIAGEN partner to develop companion diagnostic test for the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)PRNewsWire • 12/09/21
QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)Business Wire • 12/09/21
Qiagen (QGEN) Down 1.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 12/03/21
QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19Business Wire • 12/02/21
QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XSBusiness Wire • 11/29/21
QIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.529Business Wire • 11/26/21
QIAGEN Commits to Reduce Carbon Emissions by Setting Science-Based Target to Reach Net Zero by 2050Business Wire • 11/08/21
QIAGEN's (QGEN) CEO Thierry Bernard on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21
QIAGEN Reports Strong Results for Third Quarter and First Nine Months Of 2021Business Wire • 11/03/21
QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2Business Wire • 11/02/21